Clinical Trials
6
Active:0
Completed:6
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)A Multiple Ascending Dose Study of BCI-838 in Healthy Volunteers
- First Posted Date
- 2012-03-08
- Last Posted Date
- 2012-05-09
- Lead Sponsor
- BrainCells Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01548703
- Locations
- 🇳🇱
PRA International, Zuidlaren, Netherlands
A Study of BCI-838 and Several BCI-632 Prodrugs in Healthy Volunteers
- First Posted Date
- 2012-03-07
- Last Posted Date
- 2012-03-07
- Lead Sponsor
- BrainCells Inc.
- Target Recruit Count
- 31
- Registration Number
- NCT01546051
- Locations
- 🇳🇱
PRA International, Zuidlaren, Netherlands
Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety
- First Posted Date
- 2008-02-22
- Last Posted Date
- 2011-10-24
- Lead Sponsor
- BrainCells Inc.
- Target Recruit Count
- 115
- Registration Number
- NCT00621270
- Locations
- 🇨🇦
Grey Nuns Hospital, Clinical Research, Edmonton, Alberta, Canada
🇨🇦Okanagan Clinical Trials, Kelowna, British Columbia, Canada
🇨🇦Dr. Alexander McIntyre, Inc, Penticton, British Columbia, Canada
News
No news found